These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21192264)

  • 41. Assessing the economic impact of a rapid on-site malaria diagnostic test.
    Kaewsonthi S; Harding AG; Kidson C; Indaratna K
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):210-5. PubMed ID: 9279979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-penetrating glaucoma surgery: the state of play.
    Tan JC; Hitchings RA
    Br J Ophthalmol; 2001 Feb; 85(2):234-7. PubMed ID: 11159495
    [No Abstract]   [Full Text] [Related]  

  • 44. Glaucoma in oman: a review.
    Khandekarl R; Zutshi R
    J Glaucoma; 2006 Jun; 15(3):271-3. PubMed ID: 16778653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness.
    Tuulonen A; Azuara-Blanco A
    Ophthalmology; 2009 Jan; 116(1):166-7; author reply 167. PubMed ID: 19118707
    [No Abstract]   [Full Text] [Related]  

  • 46. Cost-effectiveness.
    Brown GC; Brown MM
    Ophthalmology; 2008 Aug; 115(8):1433; author reply 1433-4. PubMed ID: 18675701
    [No Abstract]   [Full Text] [Related]  

  • 47. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing the economic value of antihypertensive medicines.
    Drummond M; Coyle D
    J Hum Hypertens; 1992 Dec; 6(6):495-501. PubMed ID: 1296016
    [No Abstract]   [Full Text] [Related]  

  • 49. 56,000 Ways? No way!
    Brown GC
    Curr Opin Ophthalmol; 2006 Jun; 17(3):219-22. PubMed ID: 16794432
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment concept in glaucoma].
    Orgül S
    Praxis (Bern 1994); 2000 Jan; 89(4):151-3. PubMed ID: 10686808
    [No Abstract]   [Full Text] [Related]  

  • 51. [Possibilities, limitations, and perspectives in diagnosis and treatment of glaucoma : Tried and tested procedures in a new light].
    Lanzl IM
    Ophthalmologe; 2016 Oct; 113(10):814-815. PubMed ID: 27507576
    [No Abstract]   [Full Text] [Related]  

  • 52. Hypertension, a health economics perspective.
    Alcocer L; Cueto L
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):147-55. PubMed ID: 19124418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness.
    Lichter PR
    Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
    [No Abstract]   [Full Text] [Related]  

  • 54. A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.
    Walt JG; Lee JT
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S36-44. PubMed ID: 15016560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic costs of drug abuse: financial, cost of illness, and services.
    Cartwright WS
    J Subst Abuse Treat; 2008 Mar; 34(2):224-33. PubMed ID: 17596904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary infantile glaucoma.
    Olitsky SE
    Int Ophthalmol Clin; 2010; 50(4):57-66. PubMed ID: 20930580
    [No Abstract]   [Full Text] [Related]  

  • 57. Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.
    Oostenbrink JB; Rutten-van Mölken MP; Sluyter-Opdenoordt TS
    J Glaucoma; 2001 Jun; 10(3):184-91. PubMed ID: 11442180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of glaucoma interventions in Barbados and Ghana.
    Wittenborn JS; Rein DB
    Optom Vis Sci; 2011 Jan; 88(1):155-63. PubMed ID: 21076360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glaucoma in India.
    Thomas R; Paul P; Muliyil J
    J Glaucoma; 2003 Feb; 12(1):81-7. PubMed ID: 12567118
    [No Abstract]   [Full Text] [Related]  

  • 60. Glaucoma medical treatment--2002: does yearly cost now equal the year?
    Doyle JW; Smith MF; Tierney JW
    Optom Vis Sci; 2002 Aug; 79(8):489-92. PubMed ID: 12199540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.